Clinical Trial Update: Melatonin and Radiation Therapy in Treating Patients With Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating melatonin in combination with radiation therapy for brain metastases has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cancer

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Metastatic Cancer, Radiation Toxicity | Phase 2 | Status: COMPLETED